30 participants
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-31
- Start Date:
- 2025-11-06
- Completion:
- 2027-12-30
Conditions
- Antibody Mediated Rejection of Lung Transplant
Interventions
- DRUG
No Results Yet